secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001493152-24-049905
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab and SDSU receive NSF invitation to submit STTR application for AIR-GUIDDE technology
--------------------------------------------------------------------------------

- NSF invites QHSLab and South Dakota State University to submit full Phase I STTR application for AIR-GUIDDE drug delivery platform.
- Potential NSF funding: Phase I grants up to $305,000; Phase II up to $1.25 million.
- AIR-GUIDDE uses CFD modeling to accelerate development and target the $2.6B respiratory drug market.
- Project synergizes with QHSLab's existing digital medicine platforms and is non-dilutive to core business.
- CEO Troy Grogan says initiative validates company's innovation strategy and is fully aligned with growth plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224049905/0001493152-24-049905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224049905/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer